Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-03-01 Replacement therapy
| Fludrocortisone |
|
Formulary
|
Tablets 100micrograms Fludrocortisone has very high mineralocorticoid activity and insignificant glucocorticoid activity. A combination of hydrocortisone and fludrocortisone are needed in primary adrenal deficiency states. |
 MHRA: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration |
|
Links
- AddisonsDisease.org
- BSPED: Adrenal Insufficiency Consensus Guidelines
LSCMMG: Trans Female Gender Dysphoria Information Sheet- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- MHRA: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration
- NHSE: National Patient Safety Alert – Steroid Emergency Card to support early recognition and treatment of adrenal crisis in adults